PLAAT4

Phospholipase A and acyltransferase 4 · Q9UL19 · PLAAT4 on Sugi Atlas →

11,028 patent compounds predicted against PLAAT4, 7,493 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL26657 SCHEMBL26657 0.53 10/20
SCHEMBL1027805 SCHEMBL1027805 0.64 7/20
SCHEMBL1622156 SCHEMBL1622156 0.50 6/20
SCHEMBL710419 SCHEMBL710419 0.62 5/20
SCHEMBL694045 SCHEMBL694045 0.58 4/20
SCHEMBL660787 SCHEMBL660787 0.56 4/20
SCHEMBL991969 SCHEMBL991969 0.56 4/20
SCHEMBL553140 SCHEMBL553140 0.50 4/20
SCHEMBL442914 SCHEMBL442914 0.46 4/20
SCHEMBL1645537 SCHEMBL1645537 0.44 4/20
Phenethylcarbamic Acid Phenethylcarbamic Acid (SCHEMBL249525) 0.63 3/20
SCHEMBL1567251 SCHEMBL1567251 0.61 3/20
SCHEMBL159162 SCHEMBL159162 0.59 3/20
SCHEMBL426275 SCHEMBL426275 0.59 3/20
SCHEMBL1756655 SCHEMBL1756655 0.59 3/20
SCHEMBL440625 SCHEMBL440625 0.57 3/20
SCHEMBL1776 SCHEMBL1776 0.56 3/20
SCHEMBL1681600 SCHEMBL1681600 0.54 3/20
SCHEMBL659686 SCHEMBL659686 0.54 3/20
SCHEMBL349314 SCHEMBL349314 0.53 3/20

Clinical trials — most relevant to PLAAT4 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Omega-3 Fatty Acids on the Human Gene Expression PHASE4COMPLETED
Cystagon to Treat Infantile Neuronal Ceroid Lipofuscinosis PHASE4COMPLETED
Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT PHASE2COMPLETED
Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides PHASE1COMPLETED
Insulin Regulation of Lipolysis and Lipolysis Proteins EARLY_PHASE1RECRUITING
Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes nanCOMPLETED
A Study on Risk Mutations of Vulnerability Genes of Schizophrenia nanUNKNOWN
EPICO: (Study for the Pro-resolution of Chronic Inflammation in Obesity. Original Acronym From Spanish) nanUNKNOWN
Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in Children nanWITHDRAWN
the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease. nanUNKNOWN
Effect of Omega-3 Fatty Acids Supplementation on Hypertriglyceridemia in Pediatric Patients With Obesity. nanCOMPLETED
Genetical Background of Non-alcoholic Fatty Liver Disease (NAFLD) in Diabetes Mellitus and in Chronic Kidney Disease nanUNKNOWN
Choline to Improve Malnutrition and Enhance Cognition nanRECRUITING
Physiopathology of Pulmonary Arterial Hypertension: Mechanistic Studies nanUNKNOWN
Genomic Dissection of a QTL Affecting the Lipid Profile nanWITHDRAWN
Epidemiology of Atherosclerosis nanCOMPLETED
A 12 Week, 3-Period Study to Evaluate the Effects of a Dietary Supplement on Lipid Metabolism nanCOMPLETED
Genetic and Environmental Determinants of Triglycerides (GOLDN) nanCOMPLETED
Gene Expression in Obesity and Insulin Resistance nanCOMPLETED
Genetic Markers of CHD Risk in Men and Women nanCOMPLETED
Familial Partial Lipodystrophy Study nanCOMPLETED
The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations nanCOMPLETED
Thermogenic Silencer Regulatory Factors in Humans nanACTIVE_NOT_RECRUITING
Lipa Gene Mutation in PED-LIPIGEN (Pediatric FH Subjects) nanUNKNOWN
Role of Dairy Products in Weight Maintenance nanCOMPLETED
Serum FFA Desaturase Activity Index in Patients on High Dose Corticosteroids nanUNKNOWN
Identification of a New Gene Involved in Hereditary Lipodystrophy nanCOMPLETED
Evaluation of Botanicals for Mechanisms Related to Appetite and Fat Metabolism nanCOMPLETED
Plasma Free Fatty Acids Profile As A Diagnostic Tool For Acute Ischemic Stroke nanCOMPLETED
Screening of Healthy Adults for Genetic Variations That Control Fatty Acid Processing nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a PLAAT4 binder may also engage these)

ProteinNameSimilarity
Q9QZU4 0.984 Q9QZU4 →
Q9HDD0 0.983 Q9HDD0 →
A0A0R4IY06 0.981 A0A0R4IY06 →
D2KX21 0.979 D2KX21 →
Q9JI60 0.949 Q9JI60 →
Q93V51 0.946 Q93V51 →
O81209 0.945 O81209 →
O81211 0.944 O81211 →
Q9SW17 0.944 Q9SW17 →
Q9JI61 0.944 Q9JI61 →
Q01841 0.943 Q01841 →
O00534 0.943 O00534 →
O70370 0.942 O70370 →
P51176 0.942 P51176 →
Q99KC8 0.942 Q99KC8 →
Q92178 0.941 Q92178 →
Q3T9E4 0.941 Q3T9E4 →
Q9UIC8 0.941 Q9UIC8 →
Q91YH5 0.941 Q91YH5 →
Q9BSY9 0.941 Q9BSY9 →
Q8R3B1 0.941 Q8R3B1 →
Q91VA3 0.941 Q91VA3 →
Q9FM41 0.941 Q9FM41 →
Q7Z5M8 0.940 Q7Z5M8 →
Q5R8R3 0.940 Q5R8R3 →
Q4R802 0.940 Q4R802 →
Q9SUT8 0.940 Q9SUT8 →
Q62711 0.940 Q62711 →
Q9CQT7 0.940 Q9CQT7 →
P21981 0.940 P21981 →